BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19935874)

  • 1. Platelet-derived endothelial cell growth factor mediates angiogenesis and antiapoptosis in rat aortic endothelial cells.
    Hemalatha T; Tiwari M; Balachandran C; Manohar BM; Puvanakrishnan R
    Biochem Cell Biol; 2009 Dec; 87(6):883-93. PubMed ID: 19935874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
    Hung SC; Pochampally RR; Chen SC; Hsu SC; Prockop DJ
    Stem Cells; 2007 Sep; 25(9):2363-70. PubMed ID: 17540857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells.
    Kalishwaralal K; Banumathi E; Ram Kumar Pandian S; Deepak V; Muniyandi J; Eom SH; Gurunathan S
    Colloids Surf B Biointerfaces; 2009 Oct; 73(1):51-7. PubMed ID: 19481908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stanniocalcin, a potential ovarian angiogenesis regulator, does not affect endothelial cell apoptosis.
    Basini G; Bussolati S; Santini SE; Grasselli F
    Ann N Y Acad Sci; 2009 Aug; 1171():94-9. PubMed ID: 19723041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
    McGonigle JS; Giachelli CM; Scatena M
    Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
    Churchman A; Baydoun AR; Hoffman R
    Eur J Pharmacol; 2007 Nov; 573(1-3):176-83. PubMed ID: 17643408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
    Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
    Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.
    Stevenson DP; Milligan SR; Collins WP
    Am J Pathol; 1998 Jun; 152(6):1641-6. PubMed ID: 9626068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis.
    Florian M; Florianova L; Hussain S; Magder S
    Endothelium; 2008; 15(5-6):265-75. PubMed ID: 19065318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis.
    Meng N; Zhao J; Zhao B; Cheng Y; Wang W; Zhang Y; Zhang S; Miao J
    J Cell Biochem; 2008 Aug; 104(6):2123-30. PubMed ID: 18393353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.
    Scott AN; Hetheridge C; Reynolds AR; Nayak V; Hodivala-Dilke K; Mellor H
    Angiogenesis; 2008; 11(4):337-46. PubMed ID: 18758974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Wang Y; Wei X; Xiao X; Hui R; Card JW; Carey MA; Wang DW; Zeldin DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):522-32. PubMed ID: 15840765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells.
    Sun L; Vitolo MI; Qiao M; Anglin IE; Passaniti A
    Oncogene; 2004 Jun; 23(27):4722-34. PubMed ID: 15107836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis.
    Zania P; Kritikou S; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2006 Jul; 318(1):246-54. PubMed ID: 16595737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of emodin on angiogenesis.
    Wang XH; Wu SY; Zhen YS
    Yao Xue Xue Bao; 2004 Apr; 39(4):254-8. PubMed ID: 15303652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE; Weagant BT; Addison CL
    Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.